Genedata Selector for Biofuels, the result of years of industry collaboration, ... covers the complete biofuels R&D workflow, from genome analyses to the engineered end product.
Basel, Switzerland (PRWEB) April 26, 2012
Genedata, a leading provider of advanced software solutions for life science, biotech, and drug discovery research, today announced the new Genedata Selector™ for Biofuels will be showcased at the 2012 World Congress on Industrial Biotechnology and Bioprocessing. Part of the Genedata Selector family of industry-specific editions, the Biofuels edition is tailored to support biosynthetic engineering R&D processes. The solution provides a platform for comprehensive genomic analysis (including genotype and phenotype relationships), enabling research across the entire R&D workflow in industrial biotech and specifically biofuels industries. Out-of-the-box, Genedata Selector provides a single, integrated system in which to manage the development of new, high-value strains producing a broad spectrum of renewable chemicals. Examples of optimization of microbial and fungal production strains will be among the Genedata Selector for Biofuels posters at the 2012 BIO World Congress (April 29 – May 2).
Optimizing Strain Selection for Biofuel Production
The demand for sustainable energy resources, beyond ethanol, is driving the development of new fermentation-based production processes of biofuels. A variety of organisms, including microbes, fungi, algae, and plants are used by biofuel producers. Genedata Selector for Biofuels integrates genome data from these organisms and provides data analysis tools that enable researchers and scientists to successfully design and select the optimal strain of a specific organism for biofuel production.
Providing an innovative computational platform with built-in business logic, Genedata Selector for Biofuels uniquely delivers a single system for complete mapping of all kinds of omics and pathway data. Enterprise-level and highly-scalable, the software enables a complete view from nucleotides to patents. Additionally, it can analyze thousands of genomes to identify capabilities for efficiently producing a broad spectrum of bio-based chemicals. Specifically, the system:
- Drives innovation with advanced genomics and pathway tools that enable engineering of organisms that act as biocatalysts for the production of next-generation bio-based chemicals.
- Automatically processes data and annotates different organisms and high-quality strains.
- Highlights new gene functions across species and links them to pathways and phenotypes (e.g. strain production yields).
- Empowers the development of proprietary crops or microorganisms. The Biofuels edition comes with genomes specific to industry and research requirements.
- Facilitates a quick start. Hosted by Genedata or locally, the Biofuels edition with genome-specific data package can be up and running within a day.
- Supports genotype and phenotype data and any type of omics data. Scalable to any number of users, the Biofuels edition advances knowledge-sharing and increases operational efficiency.
“Genedata Selector for Biofuels, the result of years of industry collaboration, is truly a ground-breaking R&D technology for renewable energy,” said Dr. Othmar Pfannes, CEO of Genedata. “Unlike traditional genome comparison software, it covers the complete biofuels R&D workflow, from genome analyses to the engineered end product. We are delighted to see its increasing adoption at leading biotech and biofuel companies, which are effectively accelerating the development of unique patented crops and micro-organisms that have proprietary biosynthetic production pathways.”
Genedata transforms data into intelligence with a portfolio of advanced software solutions for drug discovery, industrial biotechnology, and life science research. Used by a majority of the world’s top 50 pharmaceutical companies and leading research organizations, Genedata solutions make research data accessible and understandable, enabling scientific discovery that fights disease and improves health and quality of life worldwide. Founded in 1997, Genedata is headquartered in Switzerland, and has offices in Japan, Germany, and the US. http://www.genedata.com
The statements in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties, including risks associated with uncertainties related to contract cancellations, developing risks, competitive factors, uncertainties pertaining to customer orders, demand for products and services, development of markets for the Company's products and services. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company undertakes no obligation to release publicly the result of any revisions to these forward-looking statements that may be made to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
All product and service names mentioned are the trademarks of their respective companies.